FDA Okays New Drug Option for Schizophrenia, Bipolar I Disorder ...Middle East

Medscape - News
The FDA has approved a once-daily oral medication, which is a combination of olanzapine and samidorphan (Lybalvi, Alkermes), for the treatment of schizophrenia and bipolar 1 disorder. FDA Approvals

Hence then, the article about fda okays new drug option for schizophrenia bipolar i disorder was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Okays New Drug Option for Schizophrenia, Bipolar I Disorder )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News